Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT

References

1. 1.↵
   2. Rosen CJ

   ; American Society for Bone and Mineral Research. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Ames: Wiley-Blackwell; 2013
2. 2.↵
   2. Mihai R,
   3. Barczynski M,
   4. Iacobone M, et al

   . Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg 2009;394:785–98 doi:10.1007/s00423-009-0529-1 pmid:19554347

   CrossRefPubMed
3. 3.↵
   2. Thomas DL,
   3. Bartel T,
   4. Menda Y, et al

   . Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy. Clin Nucl Med 2009;34:651–55 doi:10.1097/RLU.0b013e3181b591c9 pmid:19893394

   CrossRefPubMed
4. 4.↵
   2. Lindqvist V,
   3. Jacobsson H,
   4. Chandanos E, et al

   . Preoperative 99Tc(m)-sestamibi scintigraphy with SPECT localizes most pathologic parathyroid glands. Langenbecks Arch Surg 2009;394:811–15 doi:10.1007/s00423-009-0536-2 pmid:19578871

   CrossRefPubMed
5. 5.↵
   2. Smith RB,
   3. Evasovich M,
   4. Girod DA, et al

   . Ultrasound for localization in primary hyperparathyroidism. Otolaryngol Head Neck Surg 2013;149:366–71 doi:10.1177/0194599813491063 pmid:23748916

   CrossRefPubMed
6. 6.↵
   2. Levy JM,
   3. Kandil E,
   4. Yau LC, et al

   . Can ultrasound be used as the primary screening modality for the localization of parathyroid disease prior to surgery for primary hyperparathyroidism? A review of 440 cases. ORL J Otorhinolaryngol Relat Spec 2011;73:116–20 doi:10.1159/000323912 pmid:21389743

   CrossRefPubMed
7. 7.↵
   2. Rodgers SE,
   3. Hunter GJ,
   4. Hamberg LM, et al

   . Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 2006;140:932–40; discussion 940–41 doi:10.1016/j.surg.2006.07.028 pmid:17188140

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Kabala JE

   . Computed tomography and magnetic resonance imaging in diseases of the thyroid and parathyroid. Eur J Radiol 2008;66:480–92 doi:10.1016/j.ejrad.2008.03.030 pmid:18502599

   CrossRefPubMed
9. 9.↵
   2. Weber T,
   3. Maier-Funk C,
   4. Ohlhauser D, et al

   . Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 2013;257:1124–28 doi:10.1097/SLA.0b013e318289b345 pmid:23478517

   CrossRefPubMed
10. 10.↵
    2. Orevi M,
    3. Freedman N,
    4. Mishani E, et al

    . Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results. Clin Nucl Med 2014;39:1033–38 doi:10.1097/RLU.0000000000000607 pmid:25290292

    CrossRefPubMed
11. 11.↵
    2. Krausz Y,
    3. Bettman L,
    4. Guralnik L, et al

    . Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 2006;30:76–83 doi:10.1007/s00268-005-7849-2 pmid:16369710

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Lavely WC,
    3. Goetze S,
    4. Friedman KP, et al

    . Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007;48:1084–89 doi:10.2967/jnumed.107.040428 pmid:17574983

    Abstract/FREE Full Text
13. 13.↵
    2. Vaz A,
    3. Griffiths M

    . Parathyroid imaging and localization using SPECT/CT: initial results. J Nucl Med Technol 2011;39:195–200 doi:10.2967/jnmt.110.085522 pmid:21795371

    Abstract/FREE Full Text
14. 14.↵
    2. Starker LF,
    3. Mahajan A,
    4. Björklund P, et al

    . 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol 2011;18:1723–28 doi:10.1245/s10434-010-1507-0 pmid:21184187

    CrossRefPubMed
15. 15.↵
    2. Hunter GJ,
    3. Schellingerhout D,
    4. Vu TH, et al

    . Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology 2012;264:789–95 doi:10.1148/radiol.12110852 pmid:22798226

    CrossRefPubMed
16. 16.↵
    2. Kelly HR,
    3. Hamberg LM,
    4. Hunter GJ

    . 4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naive and re-exploration patients. AJNR Am J Neuroradiol 2014;35:176–81 doi:10.3174/ajnr.A3615 pmid:23868155

    Abstract/FREE Full Text
17. 17.↵
    2. Perrier ND,
    3. Edeiken B,
    4. Nunez R, et al

    . A novel nomenclature to classify parathyroid adenomas. World J Surg 2009;33:412–16 doi:10.1007/s00268-008-9894-0 pmid:19148701

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Wong KK,
    3. Fig LM,
    4. Gross MD, et al

    . Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 2015;36:363–75 doi:10.1097/MNM.0000000000000262 pmid:25642803

    CrossRefPubMed
19. 19.↵
    2. Keidar Z,
    3. Solomonov E,
    4. Karry R, et al

    . Preoperative [99mTc]MIBI SPECT/CT interpretation criteria for localization of parathyroid adenomas: correlation with surgical findings. Mol Imaging Biol 2017;19:265–70 doi:10.1007/s11307-016-1013-2 pmid:27704321

    CrossRefPubMed
20. 20.↵
    2. Neumann DR,
    3. Obuchowski NA,
    4. Difilippo FP

    . Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med 2008;49:2012–17 doi:10.2967/jnumed.108.054858 pmid:18997051

    Abstract/FREE Full Text
21. 21.↵
    2. Kluijfhout WP,
    3. Pasternak JD,
    4. Beninato T, et al

    . Diagnostic performance of computed tomography for parathyroid adenoma localization: a systematic review and meta-analysis. Eur J Radiol 2017;88:117–28 doi:10.1016/j.ejrad.2017.01.004 pmid:28189196

    CrossRefPubMed
22. 22.↵
    2. Heiba SI,
    3. Jiang M,
    4. Rivera J, et al

    . Direct comparison of neck pinhole dual-tracer and dual-phase MIBI accuracies with and without SPECT/CT for parathyroid adenoma detection and localization. Clin Nucl Med 2015;40:476–82 doi:10.1097/RLU.0000000000000778 pmid:25783516

    CrossRefPubMed
23. 23.↵
    2. Krakauer M,
    3. Wieslander B,
    4. Myschetzky PS, et al

    . A prospective comparative study of parathyroid dual-phase scintigraphy, dual-isotope subtraction scintigraphy, 4D-CT, and ultrasonography in primary hyperparathyroidism. Clin Nucl Med 2016;41:93–100 doi:10.1097/RLU.0000000000000988 pmid:26447369

    CrossRefPubMed
24. 24.↵
    2. Moosvi SR,
    3. Smith S,
    4. Hathorn J, et al

    . Evaluation of the radiation dose exposure and associated cancer risks in patients having preoperative parathyroid localization. Ann R Coll Surg Engl 2017;99:363–68 doi:10.1308/rcsann.2017.0014 pmid:28462644

    CrossRefPubMed
25. 25.↵
    2. Ray P,
    3. Vu T,
    4. Romero M, et al

    . Limiting the risks of radiation exposure in diagnostic imaging. Surgery 2014;156:1297–99 doi:10.1016/j.surg.2014.08.085 pmid:25456899

    CrossRefPubMed
26. 26.↵
    2. Hoang JK,
    3. Reiman RE,
    4. Nguyen GB, et al

    . Lifetime attributable risk of cancer from radiation exposure during parathyroid imaging: comparison of 4D CT and parathyroid scintigraphy. AJR Am J Rroentgenol 2015;204:W579–85 doi:10.2214/AJR.14.13278 pmid:25905965

    CrossRefPubMed